Putting Care at the Center is bringing together innovators from across the country to network, learn from each other, and create a shared agenda for the emerging field of complex care.
Putting Care at the Center, the inaugural conference of the National Center for Complex Health and Social Needs, will be Wednesday, December 7, through Friday, December 9, in downtown Philadelphia. We’re bringing together innovators from across the country to network, learn from each other, and create a shared agenda for the emerging field of complex care.
Attendees will learn about the science of model building, innovative funding as a lever for change, building a field to understand care, and more. The keynote address on equity in healthcare will be given by Geoffrey Canada, president of the Harlem Children’s Zone.
Attendees will also be able to participate in workshops delivered by organizations from around the country who have established models for addressing complex needs: the Southcentral Foundation, Health Leads, the National Center for Medical-Legal Partnership, Hennepin Health, the National Governor’s Association, and the Camden Coalition of Healthcare Providers. The plenary panels will be moderated by Jackie Judd, special correspondent for PBS NewsHour.
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More